New Drug Therapies in Hypertrophic Cardiomyopathy

New Drug Therapies in Hypertrophic Cardiomyopathy   Guest: Dr. Jeffrey Geske Hosts: Dr. Paul Friedman Drs. Jeffrey Geske and Paul Friedman discuss the evolving landscape of therapies from treatment of hypertrophic cardiomyopathy.  The dialogue includes novel therapies (myosin inhibitors), the evolving role of septal reduction therapy, and exploring unanswered questions. Topics Discussed: Hypertrophic Cardiomyopathy Myosin Inhibitors Septal Reduction Therapy Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.